1 completed, 1 recruiting, 1 terminated, 1 unknown. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 1, Recruiting 1, Terminated 1, Unknown 1 |
Follow Spondyloarthritis: new trials by email Literature Review of Spondyloarthritis trials Research Report on Spondyloarthritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fecal Microbiota Transplantation in Axial Spondyloarthritis FMT, Placebo - Axial Spondyloarthritis, Ankylosing Spondylitis | Phase 2 | Recruiting | University Hospital of North Norway | 99 | 2024-06-01 | 2026-08-14 |
| Study of Jitongning Tablet to Treat Spondyloarthritis Jitongning tablet(High-dose ), Jitongning tablet(Low-dose ), Placebo - Spondyloarthritis | Phase 2 | Completed | Tasly Pharmaceutical Group Co., Ltd | 238 | 2019-06-11 | 2022-11-21 |
| 99mTc-rhAnnexin V-128 in Diagnosis of Spondyloarthritis rhAnnexin V-128 - Spondyloarthritis | Phase 2 | Terminated | Advanced Accelerator Applications | 5 | 2017-09-18 | 2019-12-13 |
| Etanercept (Enbrel) in Undifferentiated Spondyloarthritis Etanercept - Spondyloarthritis | Phase 2 | Unknown | Charite University, Berlin, Germany | 8 | 2002-02-01 | 2011-02-04 |
Spondylarthritis (4) · Spondylitis, Ankylosing (2) · Arthritis (1) · Arthritis, Psoriatic (1) · Axial Spondyloarthritis (1) · Dysbiosis (1) · Inflammatory Bowel Diseases (1) · Joint Diseases (1) · Musculoskeletal Diseases (1) · Spinal Diseases (1) · Spondylitis (1)
Bone Diseases (4) · Arthritis (3) · Joint Diseases (3) · Musculoskeletal Diseases (3) · Spinal Diseases (3) · Spondylitis (3) · Ankylosis (2) · Spondylarthropathies (2) · Axial Spondyloarthritis (1) · Bone Diseases, Infectious (1) · Digestive System Diseases (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1) · Infections (1) · Intestinal Diseases (1)
Etanercept (1) · jitongning (1)
Advanced Accelerator Applications (1) · Charite University, Berlin, Germany (1) · Tasly Pharmaceutical Group Co., Ltd (1) · University Hospital of North Norway (1)
China (1) · Germany (1) · Norway (1) · United States (1)
Joachim Sieper, Prof. Dr. (1) · Rui Liu (1)
PMID 22265264, PMID 29100842, PMID 29615661, PMID 30480772, PMID 32173258, PMID 32433595